Breathe Well Live Well
|
New Report Shows Most States Fall Behind on Asthma and Allergy School Policies
PR Newswire (press release) WASHINGTON, July 30, 2013 /PRNewswire-USNewswire/ — With millions of children heading back to classrooms in the coming weeks, asthma and food allergies at school present serious concerns, but some states are better than others when it comes to … |
View full post on asthma – Google News
|
Array Shares Climb After Asthma Drug Shows Positive Phase 2 Results
Xconomy Array hopes ARRY-502 can become the next successful oral treatment for asthma, CEO Ron Squarer said during a conference call about the results. The market is substantial, and it has been 15 years since the FDA last approved an oral non-steroidal drug … |
View full post on asthma – Google News
|
Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung …
Wall Street Journal Secondary efficacy endpoints in the proof-of-concept study were also achieved, including reduced short-acting beta agonist use; asthma control; forced vital capacity improvement; symptom-free days during treatment; and improvement in rhinasthma and … Array BioPharma: ARRY-502 Meets Primary And Secondary Endpoints In … Array Biopharma To Report Top-line Results From ARRY-502 Asthma Trial |
View full post on asthma – Google News
Counsel & Heal |
Asthma medicine shows promise for Down syndrome in mice tests [Updated]
Los Angeles Times A federally approved drug already being inhaled by asthma patients may make mice with Down syndrome smarter, according to a new study. Researchers chose to test the widely manufactured bronchodilator, Formoterol, because it also acts on a brain … Using Asthma Medication, Scientists Improve Cognitive Function in Mouse … Asthma Meds May Boost Cognition in Down Syndrome Patients Drug improves cognitive function in mouse model of Down syndrome, study says |
View full post on asthma – Google News
|
Asthma medicine shows promise for Down syndrome in mice tests
Los Angeles Times The dose was far above the quantity deemed safe for asthma use in humans. Before even considering human trials, researchers will have to reduce that dosage and see if its positive effects remain. Still, the path to prescription could be shorter because … Drug improves cognitive function in mouse model of Down syndrome, Stanford … |
View full post on asthma – Google News
 SheKnows.com |
Asthma drug shows promise
SheKnows.com Regeneron Pharmaceuticals is unveiling a new experimental antibody drug that has had positive outcomes in patients who can't control the disease. About 20% of asthma patients are unsuccessful using traditional medicines to treat the disease. Results of … |
View full post on asthma – Google News
|
Boehringer Ingelheim's tiotropium shows promising results in patients with …
News-Medical.net Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society … Phase III results: tiotropium* Respimat® effective in symptomatic asthma … Boehringer Ingelheim reports positive data from symptomatic asthma trials |
View full post on asthma – Google News
 CBS Local |
Study Shows Combining 2 Inhalers Could Be Better Treatment For Asthma …
CBS Local A new study is looking at patients who have trouble controlling their condition, and suggests possibly changing the way doctors treat them. Amparo Rivera nearly died of an asthma attack last year. “The doctor had to basically put her fingers down my … Study suggests new treatment methods for asthma sufferers NZ tech leads in treatment of asthma Studies support combined prevention and rescue asthma inhaler |
View full post on asthma – Google News
 NBCNews.com (blog) |
Asthma Drug Shows Promise in Treating Hives, Study Says
New York Times An asthma drug has shown promise in relieving itchiness for patients with chronic hives who do not get relief from traditional antihistamine treatment. The drug, omalizumab, known by its brand name, Xolair, is a monoclonal antibody approved to treat … Asthma drug can ease agony of constant itch, too Asthma Drug Found Highly Effective in Treating Chronic, Severe Hives and Itch Asthma Drug Curbs Chronic Hives |
View full post on asthma – Google News
 ABC Science Online |
Asthma drug shows promise in treating diabetes, obesity
Vancouver Desi Washington, Feb 11 (IANS) Amlexanox, a drug prescribed for asthma in Japan, also reverses obesity, diabetes and fatty liver in mice, according to a new study by US researchers. “One of the reasons that diets are so ineffective in producing weight loss … Old asthma drug reverses obesity, diabetes and fatty liver in mice Asthma drug treats diabetes in obese mice Old Canker Sore Drug Effective for Weight Loss, Diabetes |
View full post on asthma – Google News